RHUMBLINE ADVISERS

Position in KZIA — Kazia Therapeutics Ltd

CIK 1115418 BOSTON, MA

Position in KZIA

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$18,247

+$7,817 QoQ

Shares Held

1,296

-7.6% QoQ

Ownership

0.011%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#31

of 35 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. KZIA ranks #301 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	396,380	$196,893,837
2	REGN	Regeneron Pharmaceuticals, Inc.	157,794	$98,390,870
3	MRNA	Moderna, Inc.	809,853	$56,714,005
4	ALNY	Alnylam Pharmaceuticals, Inc.	165,579	$49,844,246
5	INCY	Incyte Corp	428,533	$48,578,500
6	RVMD	Revolution Medicines, Inc.	226,008	$42,326,778
7	ROIV	Roivant Sciences Ltd.	1,178,789	$41,717,342
8	JAZZ	Jazz Pharmaceuticals plc	163,018	$39,282,447

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$18,247	1,296	-7.6%	Shares	Sole	2026-08-12
2026-03-31	$10,430	1,402	-10.4%	Shares	Sole	2026-05-12
2025-12-31	$10,782	1,565	+164.8%	Shares	Sole	2026-02-13
2025-09-30	$4,261	591	0.0%	Shares	Sole	2025-11-06
2025-06-30	$3,705	591	-69.1%	Shares	Sole	2025-08-12
2025-03-31	$1,490	1,911	-31.2%	Shares	Sole	2025-05-29
2024-12-31	$4,917	2,778	-90.0%	Shares	Sole	2025-05-29
2024-09-30	$11,956	27,806	+57.9%	Shares	Sole	2024-11-12
2024-06-30	$4,051	17,615	+44.7%	Shares	Sole	2024-08-01
2024-03-31	$3,772	12,170	+25.3%	Shares	Sole	2024-05-09
2023-12-31	$4,272	9,710	+28.5%	Shares	Sole	2024-02-08
2023-09-30	$7,555	7,555	0.0%	Shares	Sole	2023-11-09
2023-06-30	$8,763	7,555	—	Shares	Sole	2023-08-08
No filing history on record for this holder in this stock.